Effects of prostaglandin inhibition on the bone activities associated with the spontaneous drift of molar teeth in the rat.
Little is known about local bone regulation that enables spontaneous molar tooth drift. In this study the role of prostaglandins (PGs) were investigated in the rat by inhibiting PG-synthesis with indomethacin (7 mg/kg/d). Untreated animals were killed at the start of the experiment, while treated ones were killed after 3, 7, or 14 days of treatment. Mandibles were processed for histomorphometry without demineralization. Changes in osteoclasts and extent of the different steps of the bone remodeling sequence (resorption, reversal, and formation) were assessed along the remodeling side of the socket of the buccal root of the first molar. The total number of osteoclasts decreased after 7 days of PG inhibition (P < 0.01 vs controls) and then partially recovered. This change was due to a sharp decrease in active cells on day 7 (P < 0.01), while inactive cells remained unchanged throughout the experimental period. The extent of resorption fell on day 7 (P < 0.01) and then recovered almost to the control level on day 14. Reversal at first increased insignificantly and thereafter decreased (P < 0.02) for the remaining 7 days. Formation was modified only on day 14; at that time it had doubled compared with controls. These results show that PGs are involved in the local regulation of bone remodeling accompanying tooth drift. Resorption inhibition was partial, indicating that other factors participate with PGs in this regulation; in addition, the trend to recovery observed at the end of the experimental period suggests that these factors can take over from PGs to achieve the necessary remodeling of the socket.
Lasfargues
J J
JJ
Laboratoire de Biologie et Biomatériaux du Milieu Buccal et Osseux, Groupe Physiopathologie Osseuse, Montrouge, France.
Saffar
J L
JL
D000539:Alveolar Process / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D000818:Animals; D016723:Bone Remodeling / Q000187:drug effects*; D001862:Bone Resorption; D007213:Indomethacin / Q000494:pharmacology*; D008297:Male; D008963:Molar / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D010010:Osteoclasts / Q000187:drug effects*; D011448:Prostaglandin Antagonists; D051381:Rats; D017208:Rats, Wistar; D014085:Tooth Migration
D011448:Prostaglandin Antagonists; D007213:Indomethacin